EGFR insertions and deletions are found in roughly 15% of lung adenocarcinomas in the US, with increased frequency in nonsmokers (43% vs. 11% in smokers) [42] and Asians (up to 60% in Asian women) [43]. Here, EGFR is linked to lung adenocarcinoma.